πŸ‡ΊπŸ‡Έ FDA
Patent

US 10584105

Immunoproteasome inhibitor analogs

granted A61KA61K31/395A61K31/497

Quick answer

US patent 10584105 (Immunoproteasome inhibitor analogs) held by The Regents of the University of California expires Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/395, A61K31/497, A61K45/06, A61K9/0019